Supratentorial hemangioblastoma: Clinical features, prognosis, and predictive value of location for von HippelLindau disease

44Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Supratentorial hemangioblastoma is a rare form of hemangioblastoma; little information is available regarding prognosis, treatment, and clinical characteristics, because the available literature is primarily composed of case reports and small case series. Therefore, we performed a systematic review of the literature to analyze clinical characteristics, disease progression, and surgical outcomes with respect to survival for supratentorial hemangioblastomas. The rate of progression-free survival (PFS) was determined using Kaplan-Meier analysis. Differences in categorical factors, including location of tumor and diagnosis of von Hippel-Lindau (VHL) disease, were analyzed using the Pearson χ2 test. A total of 106 articles met the search criteria, which combined for a total of 132 patients. Of the patients with supratentorial tumors, 60 had VHL disease, and 31 (84) of 37 patients with tumors in the sellar/suprasellar region had associated VHL (χ2, P

Cite

CITATION STYLE

APA

Mills, S. A., Oh, M. C., Rutkowski, M. J., Sughrue, M. E., Barani, I. J., & Parsa, A. T. (2012, August). Supratentorial hemangioblastoma: Clinical features, prognosis, and predictive value of location for von HippelLindau disease. Neuro-Oncology. https://doi.org/10.1093/neuonc/nos133

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free